Gefticip 250mg Tablet (Geftinib)

Overview

Gefticip 250mg Tablet is a prescription anticancer medicine containing Gefitinib, which belongs to the class of tyrosine kinase inhibitors (TKIs). Primarily, it is used for the treatment of non-small cell lung cancer (NSCLC), especially in patients with EGFR gene mutations. In most cases, it is prescribed as first-line therapy or for patients who have not responded to chemotherapy. Furthermore, treatment should always be supervised by an oncologist to ensure safety and effectiveness.

Uses of Gefticip 250mg Tablet

Gefticip 250mg Tablet is commonly used for:

• Treatment of non-small cell lung cancer (NSCLC) with EGFR mutation

• Management of advanced or metastatic lung cancer

• Additionally, it may be used to slow disease progression in patients not eligible for chemotherapy

• Moreover, it helps reduce tumor growth and improve quality of life

How Gefticip 250mg Tablet Works

Gefitinib works by blocking the epidermal growth factor receptor (EGFR) tyrosine kinase, which is involved in cancer cell growth and division. As a result, cancer cells cannot multiply effectively. Consequently, this action slows tumor growth and may reduce tumor size, improving treatment outcomes.

Dosage & Administration

• Typically, Gefticip 250mg Tablet is taken orally once daily

• Moreover, it can be taken with or without food

• Importantly, the tablet should be swallowed whole with water

• Additionally, dosage and treatment duration must be strictly followed as prescribed by the oncologist

• Furthermore, regular monitoring of liver function and overall health is recommended during therapy

Possible Side Effects

Some commonly reported side effects include:

• Diarrhea

• Rash or dry skin

• Nausea

• Fatigue

• Loss of appetite

However, in rare cases, serious side effects such as liver toxicity, interstitial lung disease, or severe skin reactions may occur. Therefore, immediate medical attention is required if severe symptoms appear.

Precautions & Warnings

• Firstly, inform your doctor if you have liver disease, lung problems, or a history of heart conditions

• Secondly, pregnancy and breastfeeding should be discussed with your doctor before use

• Additionally, avoid concurrent use of strong CYP3A4 inhibitors or inducers unless approved by your doctor

• Furthermore, regular liver function tests and medical check-ups are advised throughout treatment

Storage Instructions

• Store at room temperature

• Protect from moisture and direct sunlight

• Keep out of reach of children

Packaging

Strip or box containing Gefticip 250mg Tablets